Jan C. Buckner, M.D.

  1. Oncologist
  2. Internist
  3. Chair, Oncology, Minnesota

Departments

Location

  1. Rochester, Minnesota | Jacksonville, Florida

Languages

English

Rochester, Minnesota

Jacksonville, Florida

  1. 1985
    Fellow - Medical OncologyMayo Clinic in Rochester
  2. 1983
    Internship - Internal MedicineButterworth Hospital
  3. 1983
    Resident - Internal MedicineButterworth Hospital
  4. 1980
    MDUniversity of North Carolina, Chapel Hill
  5. 1976
    BA - Chemistry and ReligionWake Forest University

Certifications

  1. 1985
    Medical OncologyAmerican Board of Internal Medicine
  2. 1983
    Internal MedicineAmerican Board of Internal Medicine

Awards and honors

  1. 2016
    NRG Oncology Outstanding ManuscriptNRG Oncology
  2. 2016
    Charles G. Moertel, M.D. Memorial LectureshipAlliance for Clinical Trials in Oncology
  3. 2015
    Betty J. Foust, M.D. and Parents' ProfessorshipMayo Clinic
  4. 2015
    NRG Oncology Outstanding AbstractNRG Oncology
  5. 2014
    Award for Excellence in Adult Clinical ResearchAmerican Society for Neuro-Oncology
  6. 2011
    Best Doctors of 2011/Medical OncologyBest Doctors in America
  7. 2008
    DOM Residency - Top EducatorMayo Clinic in Rochester
  8. 2004
    Minority Medical Student Award - Nicole MarshallMayo Clinic College of Medicine and Science, Department of Education Administration
  9. 2003
    Mayo Awards for Excellence, Excellence Through TeamworkMayo Clinic
  10. 2001
    Award for Excellence in Clinical ResearchSociety for Neuro-Oncology
  11. 1976
    Magna Cum LaudeWake Forest University
  12. 1972
    Carswell ScholarWake Forest University
See more

Professional memberships

  1. 2016
    ReviewerNational Institutes of Health, National Cancer Institute, Subcommittee A - Cancer Centers, Dana-Farber/Harvard Cancer Center Site Visit
  2. 2016 - present
    ChairEnterprise Mayo Clinic Cancer Center Executive Committee
  3. 2016 - present
    ChairEnterprise Mayo Clinic Cancer Center Practice Committee
  4. 2016 - present
    Vice ChairBoard of Directors, National Comprehensive Cancer Network
  5. 2016 - present
    Reviewer, Education BookAmerican Society of Clinical Oncology
  6. 2016 - present
    ChairNational Comprehensive Cancer Network Governance Committee
  7. 2015 - 2016
    ChairCancer Care Advisory Council Executive Committee
  8. 2015 - 2016
    Co-ChairAmerican Society for Clinical Oncology
  9. 2015
    Consultant ReviewerEORTC Independent Data Monitoring Committee
  10. 2015 - present
    Co-ChairMayo Clinic Cancer Center Practice/Research Integration Task Force
  11. 2015 - present
    ContributorEuropean Society for Medical Oncology
  12. 2014 - 2016
    MemberExternal Advisory Board, Cure Brain Tumor Foundation (Australia)
  13. 2014 - 2016
    Co-ChairCancer Care Delivery Research Coordinating Committee, National Cancer Institute, National Institutes of Health
  14. 2014 - 2016
    Cancer Service Line External Review MemberStanford University
  15. 2014
    ChairCenter for Individualized Medicine Search Committee
  16. 2014
    PanelistNational Brain Tumor Society - Brain Tumor Clinical Trial Endpoints Workshop 2: Symptoms
  17. 2014 - present
    MemberBoard of Directors, Alliance for Clinical Trials in Oncology Foundation
  18. 2014 - present
    MemberBoard of Directors, National Comprehensive Cancer Network
  19. 2014 - present
    MemberGuidelines Panel Steering Committee, National Comprehensive Cancer Network
  20. 2013 - 2016
    Cancer Care Advisory Council
  21. 2013 - 2016
    Task Force MemberNCI-AACR Cancer Patient Tobacco Use Assessment Task Force, National Cancer Institute, National Institutes of Health
  22. 2013 - 2015
    Panel MemberCNS Biomarker Reporting Panel, Cancer Biomarker Reporting Committee, College of American Pathologists
  23. 2013
    ChairBrain Tumor Advisory Board, Genentech
  24. 2012 - 2015
    ChairExternal Advisory Board, Brain Tumor Research Center, University of California, San Francisco
  25. 2012 - 2014
    MemberIT Oversight Committee, Mayo Clinic Cancer Center - Rochester, Mayo Clinic Cancer Center
  26. 2012 - 2013
    Associate DirectorCooperative Group, Mayo Clinic Cancer Center - Rochester, Mayo Clinic Cancer Center
  27. 2012
    ChairBrain Tumor Advisory Board, Genentech
  28. 2012 - present
    MemberOperations and Management Committee, Mayo Clinic Cancer Center Committees, Mayo Clinic Cancer Center
  29. 2011 - 2014
    Co-InvestigatorBrain Tumor SPORE, Project 3
  30. 2011 - 2013
    ChairSteering Committee, Cancer Control Program, Alliance for Clinical Trials in Oncology
  31. 2011 - 2013
    MemberMembership Committee, Alliance for Clinical Trials in Oncology
  32. 2011 - 2013
    Executive Committee MemberNeuro-Oncology Committee, Alliance for Clinical Trials in Oncology
  33. 2011 - 2013
    MemberFinance Committee, Alliance for Clinical Trials in Oncology
  34. 2011 - 2013
    MemberIT Systems Committee, Alliance for Clinical Trials in Oncology
  35. 2011
    Ad Hoc MemberSubcommittee A - Cancer Centers, National Cancer Institute, National Institutes of Health
  36. 2011 - present
    Board MemberAcademic and Community Cancer Research Consortium
  37. 2011 - present
    Principal InvestigatorCancer Control Program, Alliance for Clinical Trials in Oncology
  38. 2011 - present
    ChairExecutive Committee, Cancer Control Program, Alliance for Clinical Trials in Oncology
  39. 2011 - present
    MemberBoard of Directors, Alliance for Clinical Trials in Oncology
  40. 2011 - present
    MemberExecutive Committee, Alliance for Clinical Trials in Oncology
  41. 2011 - present
    MemberProgram Operations Committee, Alliance for Clinical Trials in Oncology
  42. 2011 - present
    MemberStudy Concept Review Committee, Alliance for Clinical Trials in Oncology
  43. 2011 - present
    MemberPrevention Committee, Alliance for Clinical Trials in Oncology
  44. 2011 - present
    MemberSymptom Intervention Committee, Alliance for Clinical Trials in Oncology
  45. 2011 - present
    MemberHealth Outcomes Committee, Alliance for Clinical Trials in Oncology
  46. 2011 - present
    MemberHealth Disparities Committee, Alliance for Clinical Trials in Oncology
  47. 2011 - present
    MemberCancer in the Elderly Committee, Alliance for Clinical Trials in Oncology
  48. 2011 - present
    MemberCommunity Oncology Committee, Alliance for Clinical Trials in Oncology
  49. 2010 - 2014
    ChairCooperative Group Chairs, National Cancer Institute, National Institutes of Health
  50. 2010 - 2012
    Co-ChairMCHS/MCR Oncology Council, Mayo Clinic Health System
  51. 2010
    ChairBrain Tumor Advisory Board, Genentech
  52. 2009 - 2010
    MemberOperations Efficiency Working Group, National Cancer Institute, National Institutes of Health
  53. 2009 - 2010
    Co-ChairTranslational Research Coordinating Committee, North Central Cancer Treatment Group, National Cancer Institute
  54. 2009
    External AdvisorNeuro-oncology Program, Cleveland Clinic
  55. 2008 - 2015
    MemberExternal Advisory Board, Adult Brain Tumor Consortium
  56. 2008 - 2015
    ChairData Monitoring Committee, CENTRIC Trial, EMD Serono
  57. 2008 - 2015
    MemberData Safety & Monitoring Committee, CORE Trial, EMD Serono
  58. 2008 - 2014
    Medical DirectorCancer Center Systems Management Office, Mayo Clinic Cancer Center - Rochester, Mayo Clinic Cancer Center
  59. 2008 - 2011
    MemberEducation Products Subcommittee, American Society of Clinical Oncology
  60. 2008 - 2009
    MemberAdministrative Committee of the Executive Board, Mayo Clinic Rochester - Executive Board, Mayo Clinic Rochester Committees
  61. 2008
    ConsultantGlioblastoma Multiforme Advisory Board, Bristol-Myers Squibb
  62. 2008
    ChairGlioblastoma Advisory Board, Genentech
  63. 2008 - present
    ReviewerAnnual Meeting Education Program, American Society of Clinical Oncology
  64. 2007 - 2014
    MemberExternal Advisory Committee, National Foundation for Cancer Research
  65. 2007 - 2012
    MemberExternal Advisory Board, Pediatric Brain Tumor Consortium
  66. 2007 - 2011
    ConsultantNeoPharm, Inc.
  67. 2007 - 2010
    MemberClinical Trials Management System Steering Committee, Research Bioinformation Subcommittee, Research Committee
  68. 2007 - 2010
    Co-ChairClinical Trials Management System Steering Group, National Cancer Institute, National Institutes of Health
  69. 2007 - 2008
    MemberMarketing Committee, Mayo Clinic Rochester Committees
  70. 2007 - 2008
    MemberExternal Advisory Board, Brain Tumor Funders' Collaborative
  71. 2007
    ChairGlioblastoma Advisory Board, Genentech
  72. 2007 - present
    MemberZumbro Valley Medical Society, Minnesota Medical Association
  73. 2006 - 2016
    AuthorASCO Self-Evaluation Program, American Society of Clinical Oncology
  74. 2006 - 2015
    ReviewerASCO Self-Evaluation Program, American Society of Clinical Oncology
  75. 2006 - 2007
    ChairCNS Primary Brain Tumor Project Task Force, Clinical Practice Committee - Rochester, Mayo Clinic Rochester Committees
  76. 2006 - 2007
    MemberMayo Intellectual Property Task Force, Mayo Clinic Task Forces/Work Groups
  77. 2006
    External AdvisorChildren's Oncology Group
  78. 2006
    MemberDepartment of Neuro-Oncology Review, External Advisory Board, University of Texas M.D. Anderson Cancer Center
  79. 2006
    Advisory Board MemberAMG102 in Treatment of Glioblastoma Multiforme, Amgen, Inc.
  80. 2006
    PanelistBrain Tumor Endpoints Workshop, Food and Drug Administration
  81. 2006
    MemberCentral IRB Initiative Evaluation Panel, National Cancer Institute, National Institutes of Health
  82. 2006
    MemberBrain Tumor Program, External Advisory Board, University of Texas M.D. Anderson Cancer Center
  83. 2006
    MemberExpert Panel, Patient-Reported Outcomes Assessment in Cancer Trials, Food and Drug Administration
  84. 2006
    External Advisory Board, University of Texas M.D. Anderson Cancer Center
  85. 2005 - 2008
    MemberBrain Tumor Center SPORE Grant Review, External Advisory Board, University of Texas M.D. Anderson Cancer Center
  86. 2005
    MemberEnzastaurin, Review of Product Development, Food and Drug Administration
  87. 2005 - present
    MemberPhase III Concept Evaluation, Cancer Therapy Evaluation Program, National Cancer Institute
  88. 2004 - 2011
    ChairResearch Consoritum
  89. 2004 - 2011
    ChairScientific Coordinators Committee, North Central Cancer Treatment Group, National Cancer Institute
  90. 2004
    ConsultantEli Lilly and Company
  91. 2004
    Discussant - GliadelOncologic Drug Advisory Committee, Division of Oncology Drug Products, Center for Drug Evaluation and Research
  92. 2004
    MemberEli Lilly and Company
  93. 2004
    MemberRSR-13, Review of Product Development, Food and Drug Administration
  94. 2003 - 2006
    ConsultantAnti-Sense Pharma
  95. 2003 - 2004
    MemberMKSAP Development Team, American Society of Clinical Oncology
  96. 2002 - 2014
    ChairNorth Central Cancer Treatment Group, National Cancer Institute, National Institutes of Health
  97. 2002 - 2014
    ChairAdministrative Committee, North Central Cancer Treatment Group, National Cancer Institute
  98. 2002 - 2014
    Site Visit ReviewerNeuro-Oncology Intramural Program, National Cancer Institute, National Institutes of Health
  99. 2002 - 2014
    MemberBoard of Directors, Coalition of National Cancer Cooperative Groups
  100. 2002 - 2014
    Principal InvestigatorNorth Central Cancer Treatment Group, National Cancer Institute, National Institutes of Health
  101. 2002 - 2012
    ChairExecutive Committee, Division of Medical Oncology, Department of Oncology
  102. 2002 - 2012
    MemberExternal Advisory Board, Brain Tumor Research Center, University of California, San Francisco
  103. 2002 - 2011
    ChairConcept Review Committee, North Central Cancer Treatment Group, National Cancer Institute
  104. 2002 - 2006
    Member"Blood Brain Barrier Disruption in Brain Tumor Therapy", Portland, Oregon Special Review Committee, Site Visit Committee
  105. 2002 - 2003
    MemberCommission on Cancer Work Group, Mayo Clinic Cancer Center - Rochester, Mayo Clinic Cancer Center
  106. 2002
    ModeratorResearch Recognition Dinner, American Brain Tumor Association
  107. 2002
    Site Visit ReviewerKaplan Comprehensive Cancer Center, National Cancer Institute, National Institutes of Health
  108. 2002
    MemberCNS Consortia, Special Study Section, National Cancer Institute
  109. 2002
    ReviewerNational Institutes of Health, National Cancer Institute, Subcommittee A - Cancer Centers, Johns Hopkins Sydney Kimmel Cancer Center Site Visit
  110. 2001 - 2006
    MemberIT Oversight Committee, Mayo Clinic Cancer Center - Rochester, Mayo Clinic Cancer Center
  111. 2001 - 2004
    Program DirectorClinical Trials Program, Mayo Clinic Cancer Center - Rochester, Mayo Clinic Cancer Center
  112. 2001 - 2004
    ChairClinical Research Management Team, Mayo Clinic Cancer Center - Rochester, Mayo Clinic Cancer Center
  113. 2001 - 2004
    ChairClinical and Populations Science Research Management Team (CAPERS)
  114. 2001 - 2004
    Co-DirectorClinical Research Core, Brain Tumor SPORE
  115. 2001 - 2003
    Co-ChairGonda Operations Team 10, Mayo Clinic Rochester Committees
  116. 2001
    ChairClinical Research Committee, Mayo Clinic Cancer Center - Rochester, Mayo Clinic Cancer Center
  117. 2000 - 2016
    MemberScientific Advisory Council, American Brain Tumor Association
  118. 2000 - 2012
    MemberRegional Practice Task Group, Department of Oncology
  119. 2000
    ConsultantGlioblastoma Advisory Board, Genentech
  120. 2000
    MemberRound Table Discussion with Vice-President Al Gore, American Assocation of Retired Persons
  121. 1999 - 2001
    MemberTemozolomide, Review of Product Development, Schering-Plough Research Institute
  122. 1999
    ConsultantReview New Drug Application, Food and Drug Administration
  123. 1999
    MemberResonant Stress Response, Review of Product Development, Food and Drug Administration
  124. 1998 - 2003
    Vice ChairPractice Integration Facility Subcommittee, Mayo Clinic Cancer Center - Rochester, Mayo Clinic Cancer Center
  125. 1998 - 1999
    MemberRegional Operations Committee, Mayo Clinic Health System
  126. 1998 - 1999
    MemberOutreach Work Group, Regional Operations Committee, Mayo Clinic Health System
  127. 1998 - 1999
    MemberCNS Tumors, Program Committee, American Society of Clinical Oncology
  128. 1998
    MemberHigh Cost Biotechnology Advisory Focus Group, Mayo Clinic Rochester Committees
  129. 1998
    Technical AdvisorPrimer of Brain Tumors, Seventh Edition, American Brain Tumor Association
  130. 1998
    EditorPrimer of Brain Tumors, Seventh Edition, American Brain Tumor Association
  131. 1998
    DiscussantAd Hoc Discussion of Issues Important to Seniors, Cancer Clinical Trials
  132. 1998
    MemberGadolinium Texaphyrin, Review of Product Development, Food and Drug Administration
  133. 1998
    MemberDibromodulcitol, Review of Product Development, Food and Drug Administration
  134. 1997 - 1999
    MemberBoard of Directors, Society for Neuro-Oncology
  135. 1997 - 1998
    Co-ChairThird Annual Meeting, Society for Neuro-Oncology
  136. 1997 - 1998
    MemberHead and Neck and CNS Tumors, Program Committee, American Society of Clinical Oncology
  137. 1997 - 1998
    MemberScientific Program Committee, Society for Neuro-Oncology
  138. 1997
    ChairSite Visit Team, Subcommittee D - Clinical Studies, National Cancer Institute
  139. 1997
    ConsultantWyeth-Ayerst
  140. 1997
    ConsultantSchering-Plough Research Institute
  141. 1997
    ConsultantCommon Toxicity Criteria Revision Meeting, Cancer Therapy Evaluation Program, National Cancer Institute
  142. 1997
    SWOG Site VisitSubcommittee H, National Cancer Institute, National Institutes of Health
  143. 1997
    Co-ChairCooperative Group Process Improvement Subcommittee, Operations Efficiency Working Group, National Cancer Institute
  144. 1997
    MemberSU101, Review of Product Development, Food and Drug Administration
  145. 1997
    MemberCCI-779, Review of Product Development, Wyeth-Ayerst
  146. 1997
    MemberNominations Committee, Society for Neuro-Oncology
  147. 1997
    MemberFacilities and Social Events Committee, First Scientific Meeting, Society for Neuro-Oncology
  148. 1996
    Technical AdvisorPrimer of Brain Tumors, Sixth Edition, American Brain Tumor Association
  149. 1996
    EditorPrimer of Brain Tumors, Sixth Edition, American Brain Tumor Association
  150. 1996
    ChairBy-Laws Committee, Society for Neuro-Oncology
  151. 1996
    Discussant - TemozolomideOncologic Drug Advisory Committee, Division of Oncology Drug Products, Center for Drug Evaluation and Research
  152. 1995 - 2016
    Temozolomide, Review of Product Development, Schering-Plough Research Institute
  153. 1995 - 2012
    MemberExecutive Committee, Division of Medical Oncology, Department of Oncology
  154. 1995 - 2003
    MemberExecutive Committee, Department of Oncology
  155. 1995 - 2002
    ChairClinical Practice Committee, Division of Medical Oncology, Department of Oncology
  156. 1995 - 2002
    MemberPractice Guidelines Work Group, Division of Medical Oncology, Department of Oncology
  157. 1995 - 2002
    MemberExecutive Committee, North Central Cancer Treatment Group, National Cancer Institute
  158. 1995 - 2001
    ChairData Monitoring Committee, North Central Cancer Treatment Group, National Cancer Institute
  159. 1995 - 1999
    Secretary/TreasurerSociety for Neuro-Oncology
  160. 1995 - 1996
    ChairData Safety Committee, Alkermes
  161. 1995
    MemberSubcommittee on Guidelines for Medical Oncology Fellowship, American Society of Clinical Oncology
  162. 1995 - present
    MemberSociety for Neuro-Oncology
  163. 1994 - 2014
    Vice ChairNorth Central Cancer Treatment Group, National Cancer Institute, National Institutes of Health
  164. 1994 - 2000
    Program DirectorCancer Treatment, North Central Cancer Treatment Group, National Cancer Institute
  165. 1994 - 1998
    MemberOncology Research Review Committee, Mayo Clinic Cancer Center - Rochester, Mayo Clinic Cancer Center
  166. 1994 - 1998
    MemberInternal Medicine Practice Committee, Department of Internal Medicine
  167. 1994 - 1996
    MemberAdministrative Committee, North Central Cancer Treatment Group, National Cancer Institute
  168. 1993 - 2005
    MemberProgram Committee, American Society of Clinical Oncology
  169. 1993 - 2002
    DirectorNeuro-Oncology Program, North Central Cancer Treatment Group, National Cancer Institute
  170. 1993 - 1995
    MemberCurriculum Committee, Patient Physician, and Society, Mayo Medical School, Mayo Clinic College of Medicine and Science
  171. 1993
    ReviewerSite Visit Committee, National Institutes of Health
  172. 1993
    Ad Hoc MemberSubcommittee H, National Cancer Institute, National Institutes of Health
  173. 1993
    MemberPortland, Oregon Special Review Committee, Site Visit Committee, National Institutes of Health
  174. 1992 - 1994
    ChairHuman Values in Medicine Curriculum Committee, Mayo Medical School, Mayo Clinic College of Medicine and Science
  175. 1992
    MemberFourth Year Curriculum Committee, Mayo Medical School, Mayo Clinic College of Medicine and Science
  176. 1992
    MemberHumanities in Medicine Committee, Rochester Center for Humanities in Medicine, Mayo Clinic Center for Humanities in Medicine
  177. 1989 - 1991
    MemberDevelopment Liaison Committee, Mayo Clinic Rochester Committees
  178. 1989
    MemberAd Hoc Committee on Medical Oncology Fellowship Training, American Society of Clinical Oncology
  179. 1989 - present
    FellowAmerican College of Physicians
  180. 1988 - present
    MemberAmerican Association for Cancer Research
  181. 1987 - 1994
    MemberInternal Medicine and Medical Subspecialties, Graduate Education Committee, Mayo Foundation for Medical Education and Research
  182. 1987 - 1991
    MemberMedical and Laboratory Specialties, Graduate Education Committee, Mayo Foundation for Medical Education and Research
  183. 1986 - 2016
    ConsultantMedical Education Systems, Inc.
  184. 1986 - 2016
    MemberAmerican Medical Association
  185. 1986 - 1994
    ChairEducation Committee, Division of Medical Oncology, Department of Oncology
  186. 1986 - 1994
    Program DirectorMedical Oncology Training Program, Division of Medical Oncology, Department of Oncology
  187. 1986 - present
    MemberMinnesota Medical Association
  188. 1985 - 1993
    MemberMayo Clinic Membership, North Central Cancer Treatment Group, National Cancer Institute
  189. 1985 - 1993
    Scientific CoordinatorNeuro-Oncology Program, North Central Cancer Treatment Group, National Cancer Institute
  190. 1985 - present
    MemberAmerican Society of Clinical Oncology
  191. 1984 - 1985
    FellowAmerican Cancer Society
  192. 1976 - present
    MemberPhi Beta Kappa Honor Society
  193.  
    ConsultantReview of Product Development, Food and Drug Administration
  194.  
    MemberLung and CNS Tumors, Program Committee, American Society of Clinical Oncology
See more